Erratum: The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer (Annals of Surgical Oncology (September 2005) 12 (9) (705-711) DOI: 10.1245/ASO.2005.08.020);The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer

Annals of Surgical Oncology

Volumn 12, Issue 9, 2005, Pages 705-711

  Fan, Yang Guo ^a   Tan, Yah Yuen ^a   Wu, Chen Teng ^a   Treseler, Patrick ^b   Lu, Ying ^c   Chan, Chung Wei ^a   Hwang, Shelley ^a   Ewing, Cheryl ^a   Esserman, Laura ^a   Morita, Eugene ^a   Leong, Stanley P L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Non sentinel node status; Recurrence; Sentinel lymph node; Tumor burden

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; METASTASIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; TIME SERIES ANALYSIS;

EID: 23944452315     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2005.08.513     Document Type: Erratum

References (23)

1. Ivens D, Hoe A, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
2. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.
3. Meric F, Buchholz TA, Mirza NQ, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002;9:543-9.
4. Cody HS III. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001;3:104-8.
5. Leong SP, Morita ET, Treseler PA, Wong JH. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Cancer 2000;7:105-13.
6. Treseler PA, Tauchi PS. Pathologic analysis of the sentinel lymph node. Surg Clin North Am 2000;80:1695-719.
7. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
8. Carter C, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
9. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
10. Ross MI. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA. Ann Surg Oncol 2001;8 (Suppl 9):77S-81S.
11. Wong SL, Edwards MJ, Chao C, et al. University of Louisville Breast Cancer Sentinel Lymph Node Study Group. Predicting the status of the nonsentinel axillary nodes. A multicenter study. Arch Surg 2001;136:563-8.
12. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-41.
13. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-81.
14. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
15. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9.
16. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-8.
17. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-70.
18. Roumen RM, Kuijt GP, Liem IH, Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-43.
19. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-4.
20. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection in breast cancer. Arch Surg 2003;138:482-8.
21. Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C. 200 sentinel lymph node biopsies without axillary lymph node dissection-no axillary recurrences after a 3-year follow-up. Br J Cancer 2004;90:1551-4.
22. Badgwell BD, Povoski SP, Abdessalam SF, et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 2003;10:376-80.
23. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003;138:52-6.